The University of Texas, MD Anderson Cancer Center shared; “A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.”
The lead investigator, Sarah , PhD said that, “Chemotherapy-induced peripheral neuropathy is very common in cancer patients and there is currently only one medication approved to treat it. I’m encouraged to see the significant improvements in patient’s quality of life after treatment. This treatment is customized to the individual, and is relatively inexpensive, non-invasive and non-addictive.”
It is encouraging to know that Neurofeedback (NF) can help with Peripheral neuropathy because it effects not only patients undergoing chemotherapy but others with illnesses such as Lyme disease, shingles (varicella-zoster), Epstein-Barr virus, hepatitis C, leprosy, diphtheria and HIV.
“Chronic chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy, often affecting 71 to 96 percent of patients after a month of chemotherapy treatment. Peripheral neuropathy is a set of symptoms such as pain, burning, tingling and loss of feeling caused by damage to nerves that control the sensations and movements of our arms and legs.
Neuroplasticity is the ability of the brain to form new connections and change existing ones. This study demonstrated that neurofeedback induces neuroplasticity to modulate brain activity and improve CIPN symptoms.”
The study also showed that, “After treatment, 73 percent saw improvement in their pain and quality of life. Patients with CIPN also exhibited specific and predictable EEG signatures that changed with neurofeedback.”
If you would like to learn more about neurofeedback and how it can help you, please contact me here.